dihydroxyphenylalanine has been researched along with Hepatitis C, Chronic in 1 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
Hepatitis C, Chronic: INFLAMMATION of the LIVER in humans that is caused by HEPATITIS C VIRUS lasting six months or more. Chronic hepatitis C can lead to LIVER CIRRHOSIS.
| Excerpt | Relevance | Reference |
|---|
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Capuron, L | 1 |
| Pagnoni, G | 1 |
| Drake, DF | 1 |
| Woolwine, BJ | 1 |
| Spivey, JR | 1 |
| Crowe, RJ | 1 |
| Votaw, JR | 1 |
| Goodman, MM | 1 |
| Miller, AH | 1 |
1 other study available for dihydroxyphenylalanine and Hepatitis C, Chronic
| Article | Year |
|---|---|
Dopaminergic mechanisms of reduced basal ganglia responses to hedonic reward during interferon alfa administration.
Topics: Adult; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Female; Hepatitis C, Chronic; Humans; Inte | 2012 |